Viewing Study NCT05626569


Ignite Creation Date: 2025-12-24 @ 10:54 PM
Ignite Modification Date: 2025-12-25 @ 8:22 PM
Study NCT ID: NCT05626569
Status: RECRUITING
Last Update Posted: 2024-01-03
First Post: 2022-11-17
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Anti-PD-1 Immunotherapy Combined With SBRT for Patients With Oligometastatic ESCC
Sponsor: Sun Yat-sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module